Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;59(4):2129-35.
doi: 10.1128/AAC.04841-14. Epub 2015 Jan 26.

Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations

Affiliations

Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations

Claire Andréjak et al. Antimicrob Agents Chemother. 2015 Apr.

Abstract

The Mycobacterium avium complex is the most common cause of nontuberculous mycobacterial lung disease worldwide; yet, an optimal treatment regimen for M. avium complex infection has not been established. Clarithromycin is accepted as the cornerstone drug for treatment of M. avium lung disease; however, good model systems, especially animal models, are needed to evaluate the most effective companion drugs. We performed a series of experiments to evaluate and use different mouse models (comparing BALB/c, C57BL/6, nude, and beige mice) of M. avium infection and to assess the anti-M. avium activity of single and combination drug regimens, in vitro, ex vivo, and in mice. In vitro, clarithromycin and moxifloxacin were most active against M. avium, and no antagonism was observed between these two drugs. Nude mice were more susceptible to M. avium infection than the other mouse strains tested, but the impact of treatment was most clearly seen in M. avium-infected BALB/c mice. The combination of clarithromycin-ethambutol-rifampin was more effective in all infected mice than moxifloxacin-ethambutol-rifampin; the addition of moxifloxacin to the clarithromycin-containing regimen did not increase treatment efficacy. Clarithromycin-containing regimens are the most effective for M. avium infection; substitution of moxifloxacin for clarithromycin had a negative impact on treatment efficacy.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Gross lung pathology in four strains of mice, 12 weeks after aerosol infection with M. avium (implantation of approximately 5 log10 CFU/lung). Four weeks postinfection, clarithromycin (100 mg/kg/day) was administered to a subgroup of mice.
FIG 2
FIG 2
Lung histopathology in four strains of mice, 12 weeks after aerosol infection with M. avium. Lung sections from untreated mice were stained with Ziehl-Neelsen, and red arrowheads indicate AFB. Images were captured at ×50 (BALB/c) or ×100 (C57BL/6, beige, and nude) magnification.

References

    1. Kendall BA, Winthrop KL. 2013. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med 34:87–94. doi:10.1055/s-0033-1333567. - DOI - PubMed
    1. Weiss CH, Glassroth J. 2012. Pulmonary disease caused by nontuberculous mycobacteria. Expert Rev Respir Med 6:597–613. doi:10.1586/ers.12.58. - DOI - PubMed
    1. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. 2012. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 185:881–886. doi:10.1164/rccm.201111-2016OC. - DOI - PMC - PubMed
    1. Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB. 2013. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis 19:10.3201/eid1911.130737. doi:10.3201/eid1901.111740. - DOI - PMC - PubMed
    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America . 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416. doi:10.1164/rccm.200604-571ST. - DOI - PubMed

Publication types

MeSH terms